# Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer

> **NCT00003873** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 950 (actual)

## Conditions studied

- Adenocarcinoma of the Colon
- Adenocarcinoma of the Rectum
- Recurrent Colon Cancer
- Recurrent Rectal Cancer
- Stage IV Colon Cancer
- Stage IV Rectal Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** eniluracil

## Key facts

- **NCT ID:** NCT00003873
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2007-07
- **Final completion:** —
- **Target enrollment:** 950 (ACTUAL)
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003873, "Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00003873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*